Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
Feels like a placing looming to me, the c.£12m or what’s left of it is by no means a substantial enough amount to commit to anything meaningful in the pharma industry, still holding so happy to be proved wrong but this is one dog of a share and mad Vlad is still at the wheel
I’m out, good luck to all you guys still here. I may return and I imagine I will be paying more for these at that time but it’s a marathon not a sprint and I have other fish to fry elsewhere.
Moneymunch, thanks for sharing your research I always found it extremely informative and I’m sophisticated enough to be able to read a piece of text and still make up my own mind for myself lol,
Good luck again y’all
Shoubs.
At this delay, purely because huw stated only weeks ago we were on schedule. Hope they are trying to source a bigger calculator lol, what is even more surprising though is the lack of broader interest in this share with so much potential.
Very surprised results haven’t landed within the 1/4 , only a few weeks ago Huw confirmed they were still on track in terms of timeline and to date he strikes me as quite an reliable character -
Fingers crossed for good news this week
SFX-01 reduces the viability and mammosphere colony formation ability of palbociclib-resistant cells in vitro.
Breast cancer
“Palbociclib is the leading CDK4/6 inhibitor. Marketed by Pfizer, it had sales of circa $5bn in 2019. Mammospheres are colonies of primary tumour cells which represent a disease-relevant model to study drug effectiveness.”
I wonder if Pfizer are already on alert to this news??
2 great unexpected rns this morning
SFX-01 produced tumour shrinkage and significantly extended survival times. SFX-01 was also found to potentiate (i.e. substantially increase) the therapeutic effect of radiotherapy in these models.
Alf,
Anyone who blames another man for his own investment decisions should never be investing in the first place.
You must do your own homework and paddle your own canoe in life!!
Up and down like a *****s draws lol,
The countdown is firmly on as of Monday though.
GLA
Though we were gonna crack the 10p nut for a minute there
:-(
You’ve changed your tune Ricky, last week you were “fully expecting blues days now the cln cluster duck is behind us.
Your posts read with excruciating conviction and then you change your anchor position to suit the sp movement when your prophecies to not materialise!
you are going to cost a lot of people a lot of money with your ramping antics
Tut tut
Good spot, someone showing their belief, moving early now in anticipation this morning
GLA
Jim melon is one shrewd operator, I’m happy to be invested in a company he has links to.
Hopefully next week is the week
Pingu, I understand your point, but to my mind, what they set out to achieve failed, even after numerous delays and efforts there was still not enough compelling evidence for global CO.
I agree they have big pockets etc etc however this is not a take over or a buyout of another company or product which must be far more complex in terms of due diligence, here we are simply talking about taking up an option on a product they have been involved with from day 1 and still they passed.
Now we’re left hoping and praying we can believe what Vlad says in the recent and upcoming rns’ as history clearly shows all his little hopeful insights are to be taken with a rather large pinch of salt.
Pingu,
What worries me is global CO have seen everything now, they are privvy to all the data and have the best labs on the planet but they still said no thanks when it came to take up the license option!
Vlad’s misleading tweets and update are just another example of someone with zero CEO leadership qualities. I believe he must have had a good idea global co would not take up the license hence the cln debacle, his lack of ability to lead this company has decimated the share register and the market cap.
IF the next rns says global CO have decided to cease with the program then the sp goes sub 1p imo.
Not a cricket man myself but enjoy, lovely day for it.
Mr Shoubs.
Vlad as CEO is still my biggest worry. It would do wonders for the company if he stepped aside and they appointed another pharma exec to take the reigns. Another concern is where is the update regarding global co and what happens to the sp if they decide to part ways and are not interested in the product potential as what they’ve seen to date was not encouraging enough for them to make an offer Vlad couldn’t refuse.
Its nice to be off the lows but still grave concerns at this moment in time for me.